Neuroimaging of a minipig model of Huntington's disease: Feasibility of volumetric, diffusion-weighted and spectroscopic assessments

Journal of Neuroscience Methods

Volumn 265, Issue , 2016, Pages 46-55

  Schubert, Robin ^a   Frank, Frauke ^a   Nagelmann, Nina ^a   Liebsch, Lennart ^a   Schuldenzucker, Verena ^a   Schramke, Sarah ^a,b   Wirsig, Maike ^a   Johnson, Hans ^c,d   Kim, Eun Young ^c   Ott, Stefanie ^a   Hölzner, Eva ^a   Demokritov, Sergej O ^a   Motlik, Jan ^e   Faber, Cornelius ^a   Reilmann, Ralf ^a,f  

^a UNIVERSITY OF MÜNSTER   (Germany)

^b UNIVERSITY OF VETERINARY MEDICINE HANNOVER   (Germany)

^c UNIVERSITY OF IOWA   (United States)

^d University of Iowa   (United States)

^e INSTITUTE OF ANIMAL PHYSIOLOGY AND GENETICS   (Czech Republic)

^f UNIVERSITY OF TÜBINGEN   (Germany)

Author keywords

Animal models; Brain atlas; Minipig; MRI; Preclinical research

Indexed keywords

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BODY MASS; BRAIN SIZE; COIL; CONTROLLED STUDY; DIFFUSION WEIGHTED IMAGING; ECHO PLANAR IMAGING; FEASIBILITY STUDY; FEMALE; FRACTIONAL ANISOTROPY; HUNTINGTON CHOREA; IMAGE PROCESSING; MEDICAL DEVICE; MINIPIG; NEUROIMAGING; NONHUMAN; NUCLEAR MAGNETIC RESONANCE SCANNER; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PATHOLOGICAL ANATOMY; PRIORITY JOURNAL; ANIMAL; BRAIN; DEVICES; DIAGNOSTIC IMAGING; DISEASE MODEL; METABOLISM; NUCLEAR MAGNETIC RESONANCE IMAGING; ORGAN SIZE; PIG; PROCEDURES; PROTON NUCLEAR MAGNETIC RESONANCE; TRANSGENIC ANIMAL;

ANIMALS; ANIMALS, GENETICALLY MODIFIED; BRAIN; DISEASE MODELS, ANIMAL; FEMALE; HUNTINGTON DISEASE; MAGNETIC RESONANCE IMAGING; NEUROIMAGING; ORGAN SIZE; PROTON MAGNETIC RESONANCE SPECTROSCOPY; SWINE; SWINE, MINIATURE;

EID: 84960154359     PISSN: 01650270     EISSN: 1872678X     Source Type: Journal    
DOI: 10.1016/j.jneumeth.2015.11.017     Document Type: Article

References (63)

1. Andersson J.L., Skare S., Ashburner J. How to correct susceptibility distortions in spin-echo echo-planar images: application to diffusion tensor imaging. Neuroimage 2003, 20:870-888.
2. Avants B.B., Tustison N.J., Song G., Cook P.A., Klein A., Gee J.C. A reproducible evaluation of ANTs similarity metric performance in brain image registration. Neuroimage 2011, 54:2033-2044.
3. Aylward E.H. Magnetic resonance imaging striatal volumes: a biomarker for clinical trials in Huntington's disease. Mov Disord 2014, 29:1429-1433.
4. Baxa M., et al. A transgenic minipig model of Huntington's disease. J Huntingt Dis 2013, 2:47-68.
5. Bechtel N., Scahill R.I., Rosas H.D., Acharya T., van den Bogaard S.J., Jauffret C., et al. Tapping linked to function and structure in premanifest and symptomatic Huntington disease. Neurology 2010, 75:2150-2160.
6. Brooks S.P., Dunnett S.B. Mouse models of Huntington's disease. Curr Top Behav Neurosci 2015, 22:101-133. 10.1007/7854_2013_256.:101-133.
7. Chan A.W., Jiang J., Chen Y., Li C., Prucha M.S., Hu Y., et al. Progressive cognitive deficit, motor impairment and striatal pathology in a transgenic Huntington disease monkey model from infancy to adulthood. PLoS One 2015, 10:e0122335.
8. Chan A.W., et al. A two years longitudinal study of a transgenic Huntington disease monkey. BMC Neurosci 2014, 15:36. 10.1186/1471-2202-15-36.:36-15.
9. Chan A.W., Yang S.H. Generation of transgenic monkeys with human inherited genetic disease. Methods 2009, 49:78-84.
10. Chang R., Liu X., Li S., Li X.J. Transgenic animal models for study of the pathogenesis of Huntington's disease and therapy. Drug Des Dev Ther 2015, 9:2179-2188. 10.2147/DDDT.S58470. eCollection;%2015.: 2179-2188.
11. Delmaire C., Dumas E.M., Sharman M.A., van den Bogaard S.J., Valabregue R., Jauffret C., et al. The structural correlates of functional deficits in early Huntington's disease. Hum Brain Mapp 2013, 34:2141-2153.
12. Dolezalova D., Hruska-Plochan M., Bjarkam C.R., Sorensen J.C., Cunningham M., Weingarten D., et al. Pig models of neurodegenerative disorders: utilization in cell replacement-based preclinical safety and efficacy studies. J Comp Neurol 2014, 522:2784-2801.
13. Dumas E.M., van den Bogaard S.J., Ruber M.E., Reilmann R., Stout J.C., Craufurd D., et al. Early changes in white matter pathways of the sensorimotor cortex in premanifest Huntington's disease. Hum Brain Mapp 2012, 33:203-212.
14. Ettrup K.S., Sorensen J.C., Rodell A., Alstrup A.K., Bjarkam C.R. Hypothalamic deep brain stimulation influences autonomic and limbic circuitry involved in the regulation of aggression and cardiocerebrovascular control in the Gottingen minipig. Stereotact Funct Neurosurg 2012, 90:281-291.
15. Frahm J., Bruhn H., Gyngell M.L., Merboldt K.D., Hanicke W., Sauter R. Localized proton NMR spectroscopy in different regions of the human brain in vivo. Relaxation times and concentrations of cerebral metabolites. Magn Reson Med 1989, 11:47-63.
16. Georgiou-Karistianis N., Scahill R., Tabrizi S.J., Squitieri F., Aylward E. Structural MRI in Huntington's disease and recommendations for its potential use in clinical trials. Neurosci Biobehav Rev 2013, 3:480-490.
17. Ghayoor A, Vaidya JG, Johnson HJ. Development of a novel constellation based landmark detection algorithm. 2013:86693F-6.
18. Glud A.N., Hedegaard C., Nielsen M.S., Soorensen J.C., Bendixen C., Jensen P.H., et al. Direct MRI-guided stereotaxic viral mediated gene transfer of alpha-synuclein in the Gottingen minipig CNS. Acta Neurobiol Exp (Wars) 2011, 71:508-518.
19. Hagmann P., Jonasson L., Maeder P., Thiran J.P., Wedeen V.J., Meuli R. Understanding diffusion MR imaging techniques: from scalar diffusion-weighted imaging to diffusion tensor imaging and beyond. Radiographics 2006, 26(Suppl 1):S205-S223.
20. Jacobsen J.C., Bawden C.S., Rudiger S.R., McLaughlan C.J., Reid S.J., Waldvogel H.J., et al. An ovine transgenic Huntington's disease model. Hum Mol Genet 2010, 19:1873-1882.
21. Johnson H., Harris G., Williams K. BRAINSFit: mutual information registrations of whole-brain 3D images, using the insight toolkit. Insight J. 2007, http://hdl.handle.net/1926/1291.
22. Jones A., Bienemann A., Barua N., Murison P.J., Gill S. Anaesthetic complications in pigs undergoing MRI guided convection enhanced drug delivery to the brain: a case series. Vet Anaesth Analg 2012, 39:647-652.
23. Jones D.K., Horsfield M.A., Simmons A. Optimal strategies for measuring diffusion in anisotropic systems by magnetic resonance imaging. Magn Reson Med 1999, 42:515-525.
24. Kim E.Y., Magnotta V.A., Liu D., Johnson H.J. Stable atlas-based mapped prior (STAMP) machine-learning segmentation for multicenter large-scale MRI data. Magn Reson Imaging 2014, 32:832-844.
25. Kim R.E.Y., Lourens S., Long J.D., Paulsen J.S., Johnson H.J. Preliminary analysis using multi-atlas labeling algorithms for tracing longitudinal change. Front Neurosci 2015, 9:242.
26. Lewis E.A., Smith G.A. Using drosophila models of Huntington's disease as a translatable tool. J Neurosci Methods 2016, 265:89-98.
27. Lind N.M., Moustgaard A., Jelsing J., Vajta G., Cumming P., Hansen A.K. The use of pigs in neuroscience: modeling brain disorders. Neurosci Biobehav Rev 2007, 31:728-751.
28. Mangiarini L., Sathasivam K., Seller M., Cozens B., Harper A., Hetherington C., et al. Exon 1 of the HD gene with an expanded CAG repeat is sufficient to cause a progressive neurological phenotype in transgenic mice. Cell 1996, 87:493-506.
29. Marsh J.L., Pallos J., Thompson L.M. Fly models of Huntington's disease. Hum Mol Genet 2003, 2:R187-R193. (12 Spec No, Epub;%2003 Aug 12.:R187-R193).
30. Matsui J.T., Vaidya J.G., Johnson H.J., Magnotta V.A., Long J.D., Mills J.A., et al. Diffusion weighted imaging of prefrontal cortex in prodromal Huntington's disease. Hum Brain Mapp 2014, 35:1562-1573.
31. Matsui J.T., Vaidya J.G., Wassermann D., Kim R.E., Magnotta V.A., Johnson H.J., et al. Prefrontal cortex white matter tracts in prodromal Huntington disease. Hum Brain Mapp 2015, 10:3717-3732.
32. Moran S., Chi T., Prucha M.S., Ahn K.S., Connor-Stroud F., Jean S., et al. Germline transmission in transgenic Huntington's disease monkeys. Theriogenology 2015, 84:277-285.
33. Morton A.J., Howland D.S. Large genetic animal models of Huntington's disease. J Huntingt Dis 2013, 2:3-19.
34. Norgaard G.A., Hedegaard C., Nielsen M.S., Sorensen J.C., Bendixen C., Jensen P.H., et al. Direct gene transfer in the Gottingen minipig CNS using stereotaxic lentiviral microinjections. Acta Neurobiol Exp (Wars) 2010, 70:308-315.
35. Paulsen J.S., Long J.D., Johnson H.J., Aylward E.H., Ross C.A., Williams J.K., et al. Clinical and biomarker changes in premanifest Huntington disease show trial feasibility: a decade of the PREDICT-HD study. Front Aging Neurosci 2014, 6:78. 10.3389/fnagi.2014.00078. eCollection;%2014.:78.
36. Paulsen J.S., Long J.D., Ross C.A., Harrington D.L., Erwin C.J., Williams J.K., et al. Prediction of manifest Huntington's disease with clinical and imaging measures: a prospective observational study. Lancet Neurol 2014, 13:1193-1201.
37. Phillips O., Sanchez-Castaneda C., Elifani F., Maglione V., Di P.A., Caltagirone C., et al. Tractography of the corpus callosum in Huntington's disease. PLoS One 2013, 8:e73280.
38. Pouladi M.A., Morton A.J., Hayden M.R. Choosing an animal model for the study of Huntington's disease. Nat Rev Neurosci 2013, 14:708-721.
39. Reilmann R., Leavitt B.R., Ross C.A. Diagnostic criteria for Huntington's disease based on natural history. Mov Disord 2014, 29:1335-1341.
40. Rosas H.D., Tuch D.S., Hevelone N.D., Zaleta A.K., Vangel M., Hersch S.M., et al. Diffusion tensor imaging in presymptomatic and early Huntington's disease: selective white matter pathology and its relationship to clinical measures. Mov Disord 2006, 21:1317-1325.
41. Rosendal F., Chakravarty M.M., Sunde N., Rodell A., Jonsdottir K.Y., Pedersen M., et al. Defining the intercommissural plane and stereotactic coordinates for the basal ganglia in the Gottingen minipig brain. Stereotact Funct Neurosurg 2010, 88:138-146.
42. Rosendal F., Frandsen J., Chakravarty M.M., Bjarkam C.R., Pedersen M., Sangill R., et al. New surgical technique reduces the susceptibility artefact at air-tissue interfaces on in vivo cerebral MRI in the Gottingen minipig. Brain Res Bull 2009, 80:403-407.
43. Ross C.A., Aylward E.H., Wild E.J., Langbehn D.R., Long J.D., Warner J.H., et al. Huntington disease: natural history, biomarkers and prospects for therapeutics. Nat Rev Neurol 2014, 10:204-216.
44. Saikali S., Meurice P., Sauleau P., Eliat P.A., Bellaud P., Randuineau G., et al. A three-dimensional digital segmented and deformable brain atlas of the domestic pig. J Neurosci Methods 2010, 192:102-109.
45. Sampaio C., Borowsky B., Reilmann R. Clinical trials in Huntington's disease: interventions in early clinical development and newer methodological approaches. Mov Disord 2014, 29:1419-1428.
46. Scahill R.I., Hobbs N.Z., Say M.J., Bechtel N., Henley S.M., Hyare H., et al. Clinical impairment in premanifest and early Huntington's disease is associated with regionally specific atrophy. Hum Brain Mapp 2013, 34:519-529.
47. Slow E.J., van Raamsdonk J., Rogers D., Coleman S.H., Graham R.K., Deng Y., et al. Selective striatal neuronal loss in a YAC128 mouse model of Huntington disease. Hum Mol Genet 2003, 12:1555-1567.
48. Sturrock A., Laule C., Decolongon J., Dar S.R., Coleman A.J., Creighton S., et al. Magnetic resonance spectroscopy biomarkers in premanifest and early Huntington disease. Neurology 2010, 75:1702-1710.
49. Sturrock A., Laule C., Wyper K., Milner R.A., Decolongon J., Santos R.D., et al. A longitudinal study of magnetic resonance spectroscopy Huntington's disease biomarkers. Mov Disord 2015, 30:393-401.
50. Tabrizi S.J., Langbehn D.R., Leavitt B.R., Roos R.A., Durr A., Craufurd D., et al. Biological and clinical manifestations of Huntington's disease in the longitudinal TRACK-HD study: cross-sectional analysis of baseline data. Lancet Neurol 2009, 8:791-801.
51. Tabrizi S.J., Reilmann R., Roos R.A., Durr A., Leavitt B., Owen G., et al. Potential endpoints for clinical trials in premanifest and early Huntington's disease in the TRACK-HD study: analysis of 24 month observational data. Lancet Neurol 2012, 11:42-53.
52. Tabrizi S.J., Scahill R.I., Owen G., Durr A., Leavitt B.R., Roos R.A., et al. Predictors of phenotypic progression and disease onset in premanifest and early-stage Huntington's disease in the TRACK-HD study: analysis of 36-month observational data. Lancet Neurol 2013, 12:637-649.
53. A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes [see comments]. Cell 1993, 72:971-983. The Huntington's Disease Collaborative Research Group.
54. van Oostrom J.C., Sijens P.E., Roos R.A., Leenders K.L. 1H magnetic resonance spectroscopy in preclinical Huntington disease. Brain Res 2007, 1168:67-71. (Epub;%2007 Jul 17.: 67-71).
55. Vodicka P., Smetana K., Dvorankova B., Emerick T., Xu Y.Z., Ourednik J., et al. The miniature pig as an animal model in biomedical research. Ann N Y Acad Sci 2005, 1049:161-171.
56. Voisine C., Varma H., Walker N., Bates E.A., Stockwell B.R., Hart A.C. Identification of potential therapeutic drugs for Huntington's disease using Caenorhabditis elegans. PLoS One 2007, 2:e504.
57. von Horsten S., et al. Transgenic rat model of Huntington's disease. Hum Mol Genet 2003, 12:617-624.
58. Wang H., Suh J.W., Das S.R., Pluta J., Craige C., Yushkevich P.A. Multi-atlas segmentation with joint label fusion. IEEE Trans Pattern Anal Mach Intell 2013, 3:611-623.
59. Wang H., Yushkevich P.A. Multi-atlas segmentation with joint label fusion and corrective learning-an open source implementation. Front Neuroinform 2013, 7:27. 10.3389/fninf.2013.00027. eCollection;%2013.:27.
60. Watanabe H., Andersen F., Simonsen C.Z., Evans S.M., Gjedde A., Cumming P. MR-based statistical atlas of the Gottingen minipig brain. Neuroimage 2001, 14:1089-1096.
61. Weaver K.E., Richards T.L., Liang O., Laurino M.Y., Samii A., Aylward E.H. Longitudinal diffusion tensor imaging in Huntington's disease. Exp Neurol 2009, 216:525-529.
62. Yu-Taeger L., Petrasch-Parwez E., Osmand A.P., Redensek A., Metzger S., Clemens L.E., et al. A novel BACHD transgenic rat exhibits characteristic neuropathological features of Huntington disease. J Neurosci 2012, 32:15426-15438.
63. Yun S.P., Kim D.H., Ryu J.M., Park J.H., Park S.S., Jeon J.H., et al. Magnetic resonance imaging evaluation of Yukatan minipig brains for neurotherapy applications. Lab Anim Res 2011, 27:309-316.